Skip to main content
LIVE CIN BRIEFING
Macro: Cautious · Global: Expanding · Opportunities: Selective · CMHI: 28.9
ANALYST

Wall Street Consensus

Analyst price targets, consensus ratings, and valuation multiples for cannabis equities.

View Estimates ↓
SIGNALS
BULLISH

Consensus Price Targets Rising Across Sector

Average upside potential expanding as estimates revised higher

ANALYST

Coverage Initiations Accelerating

New analyst coverage signals growing institutional interest

REGULATORY

Rescheduling Upside Not Yet Priced In

Most targets exclude Schedule III catalyst scenario

BEARISH

Short Interest Elevated on Select Names

High short ratios persist despite improving fundamentals

Fetching analyst data...

Consensus ratings and price targets reflect aggregated Wall Street analyst coverage — not CIN editorial positions.

Ticker Consensus Target Upside P/S P/B EV/EBITDA Fwd P/E Short Ratio
Fetching analyst estimates...
Complimentary Research
Would you like a deeper CIN analysis?

Request a complimentary research report combining our proprietary scoring, SEC filing analysis, and market context — scoped to the companies or themes that matter to you.

Request Complimentary Report

Terminal Dashboards

Markets
Live prices & movers
88 equities · Real-time data
Charts
Technical analysis
Interactive price history
Financials
SEC filings data
Revenue · EPS · Balance sheets
Analyst
Consensus estimates
Price targets · Ratings
Deals
Capital activity
Financing · Insider transactions
Macro
Economic context
Yields · VIX · USD · Fed
Global
International markets
13 countries · World Bank data

Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.

Cannabis Analyst Estimates and Price Targets

Access institutional cannabis analyst estimates, consensus price targets, and recommendation ratings for publicly traded cannabis companies. CIN aggregates analyst coverage from major investment banks, independent research firms, and cannabis-focused equity analysts to provide a comprehensive view of Wall Street consensus on the cannabis sector.

For each covered security, the analyst dashboard displays the consensus price target, number of covering analysts, mean recommendation rating (buy, hold, sell), implied upside or downside from current price, and recent rating changes. Analyst data is sourced from verified financial data providers and updated as new research notes are published. The CIN Take provides proprietary commentary on each company's analyst profile, contextualizing consensus estimates within broader sector trends, regulatory catalysts, and operational performance. Analyst sentiment is a key input to the Cannabis Market Health Index (CMHI), reflecting institutional conviction in the cannabis sector's forward trajectory.

Cannabis analyst coverage has expanded significantly as the sector matures, with coverage from firms including Cantor Fitzgerald, Piper Sandler, Canaccord Genuity, Jefferies, Roth Capital Partners, and ATB Capital Markets. CIN tracks both initiations of coverage and rating changes to surface inflection points in institutional sentiment toward individual cannabis operators and the sector as a whole.